Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

Peptide Therapeutics


Peptide Therapeutics has sold its Mimetrix drug discovery business to Medivir of Sweden for up to £6m, prompting speculation that Peptide could become a takeover target.
28-Mar-2000


Peptide Therapeutics is planning to acquire OraVax, the US developer of vaccines, for £9m.
12-Nov-1998